B. Longoni et al., Apoptosis and adaptive responses to oxidative stress in human endothelial cells exposed to cyclosporin A correlate with BCL-2 expression levels, FASEB J, 15(3), 2001, pp. 731-740
Treatment of transplanted patients with cyclosporin A (CSA) may cause adver
se effects such as nephrotoxicity and hypertension, As CSA is kn1own to ind
uce oxidative stress in several tissues, it may cause vascular problems by
triggering oxidative stress in endothelial cells (EC), However, oxidative s
tress has been reported for acute exposure to CSA concentrations exceeding
its clinical range, whereas immunosuppression requires life-long treatment
with therapeutic concentrations. We therefore compared the effects of 21 h
pharmacological (200 muM) vs. 8 days clinical (0.5-2.5 muM) doses of CSA on
cultured human EC. Pharmacological doses of CSA cause a decrease in cell d
ensity via apoptosis and a down-regulation of the antiapoptotic protein Bcl
-2. However, these effects are independent of CSA-induced oxidative stress.
In contrast, therapeutic concentrations of CSA cause Bcl-2 up-regulation a
nd modification of EC morphology, both effects blocked by antioxidants, The
refore, a low level of oxidants may act in EC as second messengers that up-
regulate Bcl-2, thus promoting survival of impaired EC, Our data suggest th
at the oxidative stress induced by clinical concentrations of CSA may be in
volved in the adverse effects of the drug on the vascular system of transpl
anted patients via an adaptive response involving Bcl-2 up-regulation rathe
r than an apoptotic process.-Longoni, B., Boschi, E., Demontis, G. C., Ratt
o, C. M., Mosca, F. Apoptosis and adaptive responses to oxidative stress in
human endothelial cells exposed to cyclosporin A correlate with BCL-2 expr
ession levels.